Although the majority of patients suffer from sporadic/late onset forms of AD, research is frequently conducted on transgenic mouse models carrying mutations connected to familiar/early onset forms of AD, such as a Swedish mutation of amyloid precursor protein (APP), mutation of presenilin 1 (PS1), or mutated microtubule associated protein tau (MAPT) [2]. Here, MAPT is linked to Alzheimer disease.